Clinical Trial: Study of Motilitone to Treat Functional Dyspepsia

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Double-blind, Placebo-controlled, Randomized, 4-week, Phase II Clinical Trial for Assessment of Efficacy and Safety of Motilitone in Patients With Functional Dyspepsia

Brief Summary: This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.